149 related articles for article (PubMed ID: 12562233)
1. Incidence and significance of cytoplasmic thyroid transcription factor-1 immunoreactivity.
Bejarano PA; Mousavi F
Arch Pathol Lab Med; 2003 Feb; 127(2):193-5. PubMed ID: 12562233
[TBL] [Abstract][Full Text] [Related]
2. Use of thyroid transcription factor 1, PE-10, and cytokeratins 7 and 20 in discriminating between primary lung carcinomas and metastatic lesions in fine-needle aspiration biopsy specimens.
Chhieng DC; Cangiarella JF; Zakowski MF; Goswami S; Cohen JM; Yee HT
Cancer; 2001 Oct; 93(5):330-6. PubMed ID: 11668468
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical staining for thyroid transcription factor-1: a helpful aid in discerning primary site of tumor origin in patients with brain metastases.
Srodon M; Westra WH
Hum Pathol; 2002 Jun; 33(6):642-5. PubMed ID: 12152164
[TBL] [Abstract][Full Text] [Related]
4. Variable sensitivity and specificity of TTF-1 antibodies in lung metastatic adenocarcinoma of colorectal origin.
Compérat E; Zhang F; Perrotin C; Molina T; Magdeleinat P; Marmey B; Régnard JF; Audouin J; Camilleri-Broët S
Mod Pathol; 2005 Oct; 18(10):1371-6. PubMed ID: 15861215
[TBL] [Abstract][Full Text] [Related]
5. [Diagnostic value of the monoclonal antibody to thyroid transcription factor -1(TTF-1) in CNS metastases. An immunohistochemical study of 65 cases].
Romeike BF; Feiden W
Pathologe; 2002 Jul; 23(4):292-6. PubMed ID: 12185782
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic utility of thyroid transcription factor-1 expression in adenocarcinomas presenting in serous fluids.
Afify AM; al-Khafaji BM
Acta Cytol; 2002; 46(4):675-8. PubMed ID: 12146029
[TBL] [Abstract][Full Text] [Related]
7. Monoclonal antibody to thyroid transcription factor-1: production, characterization, and usefulness in tumor diagnosis.
Holzinger A; Dingle S; Bejarano PA; Miller MA; Weaver TE; DiLauro R; Whitsett JA
Hybridoma; 1996 Feb; 15(1):49-53. PubMed ID: 9064286
[TBL] [Abstract][Full Text] [Related]
8. Utility of thyroid transcription factor-1 expression in the differential diagnosis of metastatic adenocarcinoma of serous effusion specimens prepared using the cell transfer technique.
Jan IS; Chung PF; Weng MH; Huang MS; Lee YT; Kuo SH
J Formos Med Assoc; 2006 Sep; 105(9):695-700. PubMed ID: 16959616
[TBL] [Abstract][Full Text] [Related]
9. Utility of thyroid transcription factor-1 and cytokeratin 20 in identifying the origin of metastatic carcinomas of cervical lymph nodes.
Roh MS; Hong SH
J Korean Med Sci; 2002 Aug; 17(4):512-7. PubMed ID: 12172048
[TBL] [Abstract][Full Text] [Related]
10. An immunohistochemical comparison of two TTF-1 monoclonal antibodies in atypical squamous lesions and sarcomatoid carcinoma of the lung, and pleural malignant mesothelioma.
Klebe S; Swalling A; Jonavicius L; Henderson DW
J Clin Pathol; 2016 Feb; 69(2):136-41. PubMed ID: 26281863
[TBL] [Abstract][Full Text] [Related]
11. NKX3.1 as a marker of prostatic origin in metastatic tumors.
Gurel B; Ali TZ; Montgomery EA; Begum S; Hicks J; Goggins M; Eberhart CG; Clark DP; Bieberich CJ; Epstein JI; De Marzo AM
Am J Surg Pathol; 2010 Aug; 34(8):1097-105. PubMed ID: 20588175
[TBL] [Abstract][Full Text] [Related]
12. Determination of lung as the primary site of cerebral metastatic adenocarcinomas using monoclonal antibody to thyroid transcription factor-1.
Bohinski RJ; Bejarano PA; Balko G; Warnick RE; Whitsett JA
J Neurooncol; 1998 Dec; 40(3):227-31. PubMed ID: 10066094
[TBL] [Abstract][Full Text] [Related]
13. Various Antibody Clones of Napsin A, Thyroid Transcription Factor 1, and p40 and Comparisons With Cytokeratin 5 and p63 in Histopathologic Diagnostics of Non-Small Cell Lung Carcinoma.
Tran L; Mattsson JS; Nodin B; Jönsson P; Planck M; Jirström K; Botling J; Micke P; Brunnström H
Appl Immunohistochem Mol Morphol; 2016 Oct; 24(9):648-659. PubMed ID: 26447895
[TBL] [Abstract][Full Text] [Related]
14. Surfactant proteins and thyroid transcription factor-1 in pulmonary and breast carcinomas.
Bejarano PA; Baughman RP; Biddinger PW; Miller MA; Fenoglio-Preiser C; al-Kafaji B; Di Lauro R; Whitsett JA
Mod Pathol; 1996 Apr; 9(4):445-52. PubMed ID: 8729987
[TBL] [Abstract][Full Text] [Related]
15. Combination of napsin A and TTF-1 immunohistochemistry helps in differentiating primary lung adenocarcinoma from metastatic carcinoma in the lung.
Ye J; Findeis-Hosey JJ; Yang Q; McMahon LA; Yao JL; Li F; Xu H
Appl Immunohistochem Mol Morphol; 2011 Jul; 19(4):313-7. PubMed ID: 21464700
[TBL] [Abstract][Full Text] [Related]
16. Ribonucleic Acid In Situ Hybridization Is a More Sensitive Method Than Immunohistochemistry in Detection of Thyroid Transcription Factor 1 and Napsin A Expression in Lung Adenocarcinomas.
Shi J; Liu H; Ma XJ; Chen Z; He MX; Luo Y; Lin F
Arch Pathol Lab Med; 2016 Apr; 140(4):332-40. PubMed ID: 27028392
[TBL] [Abstract][Full Text] [Related]
17. Value of thyroid transcription factor-1 and surfactant apoprotein A in the differential diagnosis of pulmonary carcinomas: a study of 109 cases.
Zamecnik J; Kodet R
Virchows Arch; 2002 Apr; 440(4):353-61. PubMed ID: 11956814
[TBL] [Abstract][Full Text] [Related]
18. Thyroid transcription factor-1 is the superior immunohistochemical marker for pulmonary adenocarcinomas and large cell carcinomas compared to surfactant proteins A and B.
Kaufmann O; Dietel M
Histopathology; 2000 Jan; 36(1):8-16. PubMed ID: 10632746
[TBL] [Abstract][Full Text] [Related]
19. Expression of thyroid transcription factor-1 in pulmonary and extrapulmonary small cell carcinomas and other neuroendocrine carcinomas of various primary sites.
Kaufmann O; Dietel M
Histopathology; 2000 May; 36(5):415-20. PubMed ID: 10792482
[TBL] [Abstract][Full Text] [Related]
20. Thyroid transcription factor-1 is highly sensitive and specific in differentiating metastatic pulmonary from extrapulmonary adenocarcinoma in effusion fluid cytology specimens.
Ng WK; Chow JC; Ng PK
Cancer; 2002 Feb; 96(1):43-8. PubMed ID: 11836702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
